Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.

MLA

Cruijsen, Marjan, et al. “Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning Is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 22, no. 6, June 2016, pp. 1000–08. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.02.003.

APA

Cruijsen, M., Hobo, W., van der Velden, W. J. F. M., Bremmers, M. E. J., Woestenenk, R., Bär, B., Falkenburg, J. H. F., Kester, M., Schaap, N. P. M., Jansen, J., Blijlevens, N. N. M., Dolstra, H., & Huls, G. (2016). Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 22(6), 1000–1008. https://doi.org/10.1016/j.bbmt.2016.02.003

Chicago

Cruijsen, Marjan, Willemijn Hobo, Walter J F M van der Velden, Manita E J Bremmers, Rob Woestenenk, Brigitte Bär, J H Frederik Falkenburg, et al. 2016. “Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning Is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 22 (6): 1000–1008. doi:10.1016/j.bbmt.2016.02.003.